1,3-dipropyl-8-cyclopentylxanthine and bw a1433

1,3-dipropyl-8-cyclopentylxanthine has been researched along with bw a1433 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobson, KA; Olah, ME; Stiles, GL1
Jacobson, KA; Ji, XD; Kim, HO; Melman, N; Olah, ME; Stiles, GL1
Jacobson, MA; Johnson, RG; Linden, J; Salvatore, CA; Taylor, HE1
Daly, JW; Hayallah, AM; Müller, CE; Preiss, B; Reith, U; Sandoval-Ramírez, J; Schobert, U; Schumacher, B1
Ensinger, HA; Leon, I; Meade, CJ; Mierau, J1
Bullough, DA; Drake, L; Firestein, GS; Mullane, KM; Sajjadi, F; Wang, J1
Berkich, DA; Crist, GH; LaNoue, KF; Xu, B1

Other Studies

7 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and bw a1433

ArticleYear
Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.
    The Journal of biological chemistry, 1994, Oct-07, Volume: 269, Issue:40

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Amino Acid Sequence; Animals; Binding Sites; Cattle; Cells, Cultured; Molecular Sequence Data; Rats; Receptors, Purinergic P1; Recombinant Fusion Proteins; Structure-Activity Relationship; Xanthines

1994
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
    Journal of medicinal chemistry, 1994, Sep-30, Volume: 37, Issue:20

    Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Brain Chemistry; Caffeine; CHO Cells; Cricetinae; Gene Expression; Iodine Radioisotopes; Molecular Structure; Phenethylamines; Phenylisopropyladenosine; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Transfection; Xanthines

1994
Molecular cloning and characterization of the human A3 adenosine receptor.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Nov-01, Volume: 90, Issue:21

    Topics: Adenosine; Amino Acid Sequence; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Consensus Sequence; Corpus Striatum; Cricetinae; DNA Primers; Gene Expression; Humans; Iodobenzenes; Kinetics; Liver; Lung; Molecular Sequence Data; Polymerase Chain Reaction; Rats; Receptors, Purinergic P1; Sequence Homology, Amino Acid; Sheep; Transfection

1993
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Journal of medicinal chemistry, 2002, Mar-28, Volume: 45, Issue:7

    Topics: Amines; Animals; Benzoic Acid; Cell Line; CHO Cells; Cricetinae; Fibroblasts; Humans; Kinetics; Models, Chemical; Protein Binding; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Structure-Activity Relationship; Transfection; Xanthines

2002
In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:3

    Topics: Adenosine; Animals; Atropine; Blood Pressure; Bronchial Spasm; Female; Injections, Intravenous; Lung; Male; Mast Cells; Neuropeptides; Peptides, Cyclic; Purinergic P1 Receptor Agonists; Rats; Receptors, Neurokinin-2; Receptors, Purinergic P1; Vagotomy; Xanthines

1996
Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Animals; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Myocardium; Polymerase Chain Reaction; Purinergic P1 Receptor Antagonists; Rabbits; Receptors, Purinergic P1; Theophylline; Transcription, Genetic; Xanthines

1997
A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats.
    The American journal of physiology, 1998, Volume: 274, Issue:2

    Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Brain; Female; Glucose; Glucose Tolerance Test; Glycerol; Insulin Resistance; Lipolysis; Male; Muscle, Skeletal; Obesity; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Rats, Zucker; Xanthines

1998